SCHEMBL8308919

SCHEMBL8308919

CCOC(=O)/C=C/c1cc2cc(Cl)c(Cl)cc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATP6AP1 Q15904 1/20 0.52
ATP6V1B1 P15313 3/20 0.46
TTR P02766 1/20 0.42
DPP4 P27487 1/20 0.42
P2RY12 Q9H244 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CYP3A4 P08684 1/20 0.40
MAPT P10636 3/20 0.40
KDM4E B2RXH2 1/20 0.40
FDPS P14324 1/20 0.40
ALOX15 P16050 1/20 0.39
MAOB P27338 1/20 0.39
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8308921 1.00 ATP6AP1 (0.52) ATP6AP1ATP6V1B1TTRDPP4P2RY12
SCHEMBL2239744 0.80 ATP6V1B1 (0.51) ATP6V1B1TTRDPP4P2RY12CA12
SCHEMBL2239741 0.80 ATP6V1B1 (0.51) ATP6V1B1TTRDPP4P2RY12CA12
SCHEMBL24601171 0.79 CYP2A6 (0.44) TTRDPP4P2RY12CA12CA1
SCHEMBL6295560 0.78 ATP6AP1 (0.53) ATP6AP1ATP6V1B1CYP3A4KDM4E
SCHEMBL6295563 0.78 ATP6AP1 (0.53) ATP6AP1ATP6V1B1CYP3A4KDM4E
SCHEMBL22074483 0.78 NPC1 (0.50) TTRDPP4CA2CYP3A4MAPT
SCHEMBL30684333 0.78 TTR (0.42) TTRDPP4P2RY12CA12CA1
SCHEMBL26912859 0.78 TTR (0.42) TTRDPP4P2RY12CA12CA1
SCHEMBL1420129 0.76 DNTT (0.42) TTRDPP4P2RY12CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5985905-A USEFUL FOR THE TREATMENT AND/OR PROPHYLAXIS OF DISEASES ASSOCIATED WITH LOSS OF BONE MASS, SUCH AS OSTEOPOROSIS AND RELATED OSTEOPENIC DISEASES, PAGET'S DISEASE, HYPERPARATHYROIDISM AND RELATED DISEASES, ALSO ANTITUMOR ENCYSIVE PHARMACEUTICALS, INC. 1999-11-16 US disclosed
US-5981525-A FOR THERAPY OR PROPHYLAXIS OF OSTEOPOROSIS,TUMOURS, ULCERS, AUTOIMMUNE DISEASES, LIPIDEMIC DISORDERS, HYPERCHOLESTEROLEMIC AND ATHEROSCLEROTIC DISEASES, AIDS ALZHEIMER'S DISEASE SMITHKLINE BEECHAM CORPORATION (US) 1999-11-09 US disclosed
EP-0912560-A1 INDOLE DERIVATIVES FOR THE TREATMENT OF OSTEOPOROSIS Smithkline Beecham S.p.A. (IT) 1999-05-06 EP disclosed
WO-1998001445-A1 INDOLE DERIVATIVES FOR THE TREATMENT OF OSTEOPOROSIS SMITHKLINE BEECHAM S.P.A. (IT) 1998-01-15 WO disclosed
EP-0802902-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS Smithkline Beecham S.p.A. (IT) 1997-10-29 EP disclosed
WO-1996021644-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS SMITHKLINE BEECHAM S.P.A. (IT) 1996-07-18 WO disclosed